CEACAM5 and non-small cell lung carcinoma: The diagnostic power of this lncRNA was greater than that of conventional biomarkers such as CEA and CYFRA21-1, and additionally worked for early-stage NSCLC, speaking to the promise of lncRNAs to detect early disease [102].